RxNorm 402243 NDC Crossover
bortezomib 3.5 MG Injection
Related NDC Codes to RxNorm Concept 402243
The following NDC codes crossover to the RxNorm Concept 402243. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0143-9098 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | ACTIVE | |
0409-1700 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
0781-3258 | Bortezomib | Bortezomib For Injection | Injection, Powder, Lyophilized, For Solution | Intravenous | Sandoz Inc | ACTIVE | |
10019-991 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Baxter Healthcare Corporation | ACTIVE | |
25021-244 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | ACTIVE | |
43598-426 | Bortezomib | Bortexomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Dr.reddy's Laboratories, Inc. | ACTIVE | |
43598-865 | Bortezomib | Bortexomib | Injection, Powder, Lyophilized, For Solution | Intravenous | Dr.reddy's Laboratories Inc | ACTIVE | |
50742-484 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Ingenus Pharmaceuticals, Llc | ACTIVE | |
51817-586 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Pharmascience Inc. | ACTIVE | |
55150-337 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Eugia Us Llc | ACTIVE | |
60505-6050 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Apotex Corp | ACTIVE | |
63020-049 | Velcade | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
63323-821 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
67184-0530 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Qilu Pharmaceutical Co., Ltd. | ACTIVE | |
68001-534 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
68001-540 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
68001-541 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
70710-1411 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Zydus Pharmaceuticals Usa Inc. | ACTIVE | |
70771-1708 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Zydus Lifesciences Limited | ACTIVE | |
70860-225 | Bortezomib | Athenex Pharmaceutical Division, Llc. | INACTIVATED | ||||
71288-118 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
72205-183 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Novadoz Pharmaceuticals Llc | ACTIVE | |
83090-008 | Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Sintetica Us Llc | ACTIVE |